Xenon Pharmaceuticals Inc (XENE) — Analysis Summary
Xenon Pharmaceuticals Inc (XENE) has a market cap of $5.07B with year-over-year revenue growth of -20.5%. Net margin stands at -4612.1%. The stock trades at a P/E ratio of -13.2.
Key Takeaways
- Revenue changed -20.5% year-over-year
- Net margin of -4612.1%
- P/E ratio of -13.2
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, XENE posted revenue growth of -20.5% and trades at a P/E of -13.2.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.